For the last 30 years, TePe has been the leader in interdental ... On the one hand, it's sad not to be meeting up in person with dental care professionals. Due to our educational programme ...

Learn more about how we test and review oral care products. Health's content is for informational and educational purposes only. Our website is not intended to be a substitute for professional ...

Bruush Oral Care Inc., an oral care company, manufactures and sells electric toothbrushes in the United States and Canada. It offers Brüush starter kit, including electric toothbrush, three brush ...

Learn which meds might cause oral side effects. Many different types of oral health care providers could become involved in the care of your teeth, gums, and mouth. You and your dentist will be ...

Bruush Oral Care Inc (BRSHF) has released an update. Bruush Oral Care Inc. has appointed Ramirez Jimenez International CPAs as its new independent auditor to finalize its financial statements for ...

Medicare, and Medicare Advantage plans. Sign up for our Health Care Inc. email newsletter here, delivered to your inbox every Monday.

The Affordable Care Act (ACA) established national standards for health insurance plans, but some health insurance companies are better than others when it comes to delivering quality and value.

October 25, 2024 • There's something strange going on in hospitals. Cheap, common drugs that nurses use every day seem to be constantly hit by shortages. These are often generic drugs that don't ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In evaluating the best states for health care – one of eight categories driving the overall Best States rankings – U.S. News examined metrics reflecting health care access, health care quality ...

Viking Therapeutics released new data on an obesity pill that may eventually compete with blockbuster shots from Eli Lilly and Novo Nordisk, stoking further takeout speculation for the company.